- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Celgene Corporation (CELG)"Celgene Corporation stock price live, this page displays NASDAQ CELG stock exchange data. View the CELG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Celgene Corporation real time stock price chart below.
What Is the Celgene Corporation Stock Price Today?
The Celgene Corporation stock price today is 108.24.
What Is the Stock Symbol for Celgene Corporation?
The stock symbol for Celgene Corporation is ""CELG.""
What Stock Exchange Does Celgene Corporation Trade On?
Celgene Corporation is listed and trades on the NASDAQ stock exchange.
Is Celgene Corporation a Good Stock to Buy?
Determining whether Celgene Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CELG quote. (ISIN: US1510201049)"
What Is the Celgene Corporation Stock Price Today?
The Celgene Corporation stock price today is 108.24.
What Is the Stock Symbol for Celgene Corporation?
The stock symbol for Celgene Corporation is ""CELG.""
What Stock Exchange Does Celgene Corporation Trade On?
Celgene Corporation is listed and trades on the NASDAQ stock exchange.
Is Celgene Corporation a Good Stock to Buy?
Determining whether Celgene Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CELG quote. (ISIN: US1510201049)"
NASDAQ
Currency in USD
108.24
0.00(0.00%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
107.27
108.59
52 wk Range
0.00
108.59
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
107.27108.59
52 wk Range
0.00108.59
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockCELG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Currently not supported.
- Stocks - S&P Knocked Down by Boeing, JNJ, China
- Investing.com
- Stocks - S&P Knocked Down by Boeing, JNJ, China
- Investing.com
Celgene Corporation Company Profile
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. The company offers ABRAXANE, a paclitaxel powder for injectable suspension nanoparticle; IDHIFA that are enasidenib tablets; INREBIC, which are fedratinib capsules; ISTODAX, a lyophilized powder for injection; ONUREG that are azacitidine tablets; POMALYST, pomalidomide capsules; REBLOZYL, an injection for luspatercept; REVLIMID that are lenalidomide capsules; THALOMID, which are thalidomide capsules; VIDAZA, an injection of azacytidine; and ZEPOSIA that are ozanimod capsules. It provides pharmaceuticals in the areas of oncology, hematology, immunoscience, cardiovascular disease, and fibrosis. The company was incorporated in 1986 and is based in Summit, New Jersey. Celgene Corporation operates as a subsidiary of Bristol-Myers Squibb Company.
Compare CELG to Peers and Sector
Metrics to compare | CELG | Peers Peers - average of corresponding metrics from companies closely matching CELG: | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCELGPeersSector |
|---|---|---|---|---|
P/E Ratio | 0.0x | 0.0x | 0.0x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 0.0x | 0.0x | |
Price / LTM Sales | 0.0x | 0.0x | 0.0x | |
Upside (Analyst Target) | 0.0% | 0.0% | 0.0% | |
Fair Value Upside | Unlock | 0.0% | 0.0% | Unlock |
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.